Prevalence of metabolic syndrome among patients with schizophrenia in Japan (Q45592684)

14 December 2017

title

Prevalence of metabolic syndrome among patients with schizophrenia in Japan (English)

1 reference

14 December 2017

0 references

1 reference

2

Norio Yasui-Furukori

1 reference

14 December 2017

11

Shigeyuki Nakaji

1 reference

14 December 2017

4

Takashi Umeda

1 reference

14 December 2017

Norio Sugawara

1

1 reference

14 December 2017

Yasushi Sato

3

1 reference

14 December 2017

Ikuko Kishida

5

1 reference

14 December 2017

Hakuei Yamashita

6

1 reference

14 December 2017

Manabu Saito

7

1 reference

14 December 2017

Hanako Furukori

8

1 reference

14 December 2017

Taku Nakagami

9

1 reference

14 December 2017

Mitsunori Hatakeyama

10

1 reference

14 December 2017

Sunao Kaneko

12

1 reference

14 December 2017

language of work or name

English

0 references

publication date

17 September 2010

1 reference

full work available at URL

14 December 2017

https://api.elsevier.com/content/article/PII:S092099641001501X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

https://api.elsevier.com/content/article/PII:S092099641001501X?httpAccept=text/plain

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

15 July 2024

published in

Schizophrenia Research

1 reference

14 December 2017

volume

123

1 reference

14 December 2017

issue

2-3

1 reference

14 December 2017

page(s)

244-250

1 reference

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation

14 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Consensus development conference on antipsychotic drugs and obesity and diabetes

15 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Prevalence of metabolic syndrome in the general Japanese population in 2000

15 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

The prevalence of the metabolic syndrome in patients with schizoaffective disorder--bipolar subtype

15 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study.

15 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Prevalence of metabolic syndrome among inpatients with schizophrenia.

15 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Causes of the excess mortality of schizophrenia

15 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome

15 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Body weight and self-esteem in patients with schizophrenia evaluated with B-WISE.

15 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

New criteria for 'obesity disease' in Japan.

15 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

15 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Metabolic profile of antipsychotic-naive individuals with non-affective psychosis

15 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

15 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Hypertriglyceridemia, insulin resistance, and the metabolic syndrome

15 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

15 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study

15 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Waist-to-height ratio, a simple and practical index for assessing central fat distribution and metabolic risk in Japanese men and women

15 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Prevalence of metabolic syndrome among patients with schizophrenia or schizoaffective disorder in Taiwan.

15 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Cardiovascular morbidity and mortality associated with the metabolic syndrome

15 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

The hypothalamic-pituitary-adrenal axis in chronic schizophrenic patients long-term treated with neuroleptics

15 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

15 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Modification of the relationship between simple anthropometric indices and risk factors by ethnic background

15 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Effective cut-off values of waist circumference to detect the clustering of cardiovascular risk factors of metabolic syndrome in Japanese men and women.

15 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Medical comorbidity in psychiatric inpatients: relation to clinical outcomes and hospital length of stay

15 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

15 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome.

15 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: the Hisayama study

15 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Mortality and causes of death in schizophrenia in Stockholm county, Sweden

15 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

The link between abdominal obesity and the metabolic syndrome

15 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Physical consequences of schizophrenia and its treatment: the metabolic syndrome

15 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

15 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Metabolic syndrome in first episode schizophrenia - a randomized double-blind controlled, short-term prospective study.

15 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Metabolic syndrome in outpatients receiving antipsychotic therapy in routine clinical practice: a cross-sectional assessment of a primary health care database

15 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Metabolic syndrome in Thai schizophrenic patients: a naturalistic one-year follow-up study

15 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey.

15 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?

15 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia

15 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Obesity as a risk factor for antipsychotic noncompliance.

15 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus

15 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.030

15 July 2024

Identifiers

1 reference

14 December 2017

1 reference